Increased Gene Copy Number of DEFA1A3 Is Associated With the Severity of Ulcerative Colitis. Issue 4 (6th April 2021)

• Record Type: Journal Article
• Authors: Kanmura, Shuji; Morinaga, Yuko; Tanaka, Akihito; Komaki, Yuga; Iwaya, Hiromichi; Kumagai, Kotaro; Mawatari, Seiichi; Sasaki, Fumisato; Tanoue, Shiroh; Hashimoto, Shinichi; Sameshima, Yoichi; Ono, Yohei; Ohi, Hidehisa; Ido, Akio
• Is Part Of: Clinical and translational gastroenterology. Volume 12:Issue 4(2021)
• Page Start: e00331
• Publication Date: 2021-04-06
• Subjects: Stomach -- Diseases -- Periodicals; Intestines -- Diseases -- Periodicals; Gastroenterology; Gastrointestinal Diseases; Liver Diseases; Intestines -- Diseases; Stomach -- Diseases; Periodical; Periodicals; Fulltext; Internet Resources; Periodicals; Electronic journals; 616.33
• DOI: 10.14309/ctg.0000000000000331
• Languages: English
• ISSNs: 2155-384X

Abstract

Abstract : INTRODUCTION: DEFA1A3 encodes human neutrophil peptides (HNPs) 1–3 and has multiple copy number variations (CNVs). HNPs are associated with innate immunity. Ulcerative colitis (UC), a chronic inflammatory gastrointestinal disorder, is a life-threatening condition, and predictive markers of UC severity are needed. This study investigated the relationship between DEFA1A3 CNV and UC severity. METHODS: This study enrolled 165 patients with UC. The relationship between DEFA1A3 CNV and disease severity was analyzed based on Mayo score, patient characteristics, and treatment methods. In addition, serum and stimulated neutrophil-derived HNP concentrations were also measured in patients with high and low DEFA1A3 CNV. RESULTS: DEFA1A3 CNV was significantly correlated with Mayo score and white blood cell count ( R = 0.46, P < 0.0001; R = 0.29, P = 0.003, respectively), and only high copy numbers of DEFA1A3 were independent factors for severe UC ( P < 0.001, odds ratio: 1.88, 95% confidence interval, 1.34–2.61). The number of severe UC patients with high DEFA1A3 CNV was significantly greater than those with low CNV. We confirmed the associations between DEFA1A3 and UC severity using a validation cohort. In addition, the HNP concentration in high-copy number patients was significantly higher after neutrophil stimulation than that in low-copy number patients. DISCUSSION: This study demonstrated that there is a correlation between DEFA1A3 copy number and severity in patients with UC. In addition, neutrophils from UC patients with higher DEFA1A3 CNV had high reactivity of secretion of HNPs after stimulation. DEFA1A3 CNV may be a novel severity marker and a potential therapeutic target for UC.